Opportunity ID: 362246
General Information
| Funding Opportunity Number | HT942526MRPSRA |
| Funding Opportunity Title | DoW Melanoma Research Program Survivorship Research Award |
| Agency | Jamie Shortall Grant Officer |
| Document Type | synopsis |
| Version | 1 |
| Opportunity Category | Discretionary |
| Opportunity Category Explanation | Not specified |
| Funding Instrument Type | Grant |
| Category of Funding Activity | Science and Technology and other Research and Development |
| Category Explanation | Not specified |
| Expected Number of Awards | 2 |
| Cost Sharing or Matching Requirement | No |
| Posted Date | May 21, 2026 12:00:00 AM EDT |
| Last Updated Date | May 21, 2026 12:20:37 PM EDT |
| Original Closing Date | Oct 14, 2026 12:00:00 AM EDT |
| Original Closing Date Notes | Not specified |
| Current Closing Date | Oct 14, 2026 12:00:00 AM EDT |
| Current Closing Date Notes | Not specified |
| Estimated Synopsis Date | Not specified |
| Estimated Application Due Date | Not specified |
| Estimated Award Date | Not specified |
| Estimated Project Start Date | Not specified |
| Archive Date | Nov 13, 2026 12:00:00 AM EST |
| Estimated Total Program Funding | 2,040,000 |
| Award Ceiling | none |
| Award Floor | none |
Assistance Listings
- 12.420 — Military Medical Research and Development
Eligibility
| Eligible Applicants | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
Description
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
Distinctive Features:
· The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research.
· Clinical trials are allowed.
Additional Information
| Contact | Jamie Shortall Grant Officer |
| Contact Information | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| help@eBRAP.org | |
| Email Description | eBRAP Help Desk |
| Phone | 301-619-2393 |
Additional information
Version History
Version history
| Opp hist id / Opportunity id | 362246 |
| Opp hist id / Revision | 0 |
| Opportunity id | 362246 |
| Revision | 0 |
| Opportunity number | HT942526MRPSRA |
| Opportunity title | Melanoma Research Program Survivorship Research Award |
| Owning agency code | DOD-AMRAA |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Forecast / Opp hist id / Opportunity id | 362246 |
| Forecast / Opp hist id / Revision | 0 |
| Forecast / Opportunity id | 362246 |
| Forecast / Revision | 0 |
| Forecast / Version | 1 |
| Forecast / Posting date | May 05, 2026 12:00:00 AM EDT |
| Forecast / Forecast desc | Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
Distinctive Features: · The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research. · Clinical trials are allowed. Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $2.04M to fund approximately two Survivorship Research Award applications with total cost caps of $1.02M per award. The maximum period of performance is 3 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027. https://cdmrp.health.mil/pubs/press/2026/mrppreann |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 2 |
| Forecast / Estimated funding | 2040000 |
| Forecast / Award ceiling | none |
| Forecast / Award floor | none |
| Forecast / Agency contact name | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Forecast / Agency contact phone | 301-682-5507 |
| Forecast / Agency contact email | help@eBRAP.org |
| Forecast / Agency contact email desc | eBRAP Help Desk |
| Forecast / Agency code | DOD-AMRAA |
| Forecast / Applicant eligibility desc | Not specified |
| Forecast / Est synopsis posting date | Jun 01, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Oct 14, 2026 12:00:00 AM EDT |
| Forecast / Est application response date desc | Not specified |
| Forecast / Est award date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Est project start date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2026 |
| Forecast / Create time stamp | May 05, 2026 03:12:11 PM EDT |
| Forecast / Action type | U |
| Forecast / Action date | May 06, 2026 01:53:35 PM EDT |
| Forecast / Created date | May 05, 2026 03:12:11 PM EDT |
| Forecast / Last updated date | May 05, 2026 03:12:11 PM EDT |
| Forecast / Agency details / Code | AMRAA |
| Forecast / Agency details / Seed | DOD-AMRAA |
| Forecast / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Forecast / Agency details / Agency code | DOD-AMRAA |
| Forecast / Agency details / Top agency code | DOD |
| Forecast / Estimated funding formatted | 2,040,000 |
| Forecast / Applicant types 1 / Id | 99 |
| Forecast / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Forecast / Funding instruments 1 / Id | CA |
| Forecast / Funding instruments 1 / Description | Cooperative Agreement |
| Forecast / Funding instruments 2 / Id | G |
| Forecast / Funding instruments 2 / Description | Grant |
| Forecast / Funding activity categories 1 / Id | ST |
| Forecast / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Forecast / Posting date str | 2026-05-05-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-06-01-00-00-00 |
| Forecast / Est application response date str | 2026-10-14-00-00-00 |
| Forecast / Est award date str | 2027-09-30-00-00-00 |
| Forecast / Est project start date str | 2027-09-30-00-00-00 |
| Forecast / Create time stamp str | 2026-05-05-15-12-11 |
| Cfdas 1 / Id | 433151 |
| Cfdas 1 / Opportunity id | 362246 |
| Cfdas 1 / Revision | 1 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Synopsis modified fields | Not specified |
| Forecast modified fields | Not specified |
| Opp hist id / Opportunity id | 362246 |
| Opp hist id / Revision | 2 |
| Opportunity id | 362246 |
| Revision | 2 |
| Opportunity number | HT942526MRPSRA |
| Opportunity title | DoW Melanoma Research Program Survivorship Research Award |
| Owning agency code | DOD-AMRAA |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Modified comments | Adding "DoW" to the opportunity title |
| Forecast / Opp hist id / Opportunity id | 362246 |
| Forecast / Opp hist id / Revision | 2 |
| Forecast / Opportunity id | 362246 |
| Forecast / Revision | 2 |
| Forecast / Version | 2 |
| Forecast / Posting date | May 05, 2026 12:00:00 AM EDT |
| Forecast / Forecast desc | Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
Distinctive Features: Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $2.04M to fund approximately two Survivorship Research Award applications with total cost caps of $1.02M per award. The maximum period of performance is 3 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027. https://cdmrp.health.mil/pubs/press/2026/mrppreann |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 2 |
| Forecast / Estimated funding | 2040000 |
| Forecast / Award ceiling | none |
| Forecast / Award floor | none |
| Forecast / Agency contact name | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Forecast / Agency contact phone | 301-682-5507 |
| Forecast / Agency contact email | help@eBRAP.org |
| Forecast / Agency contact email desc | eBRAP Help Desk |
| Forecast / Agency code | DOD-AMRAA |
| Forecast / Applicant eligibility desc | Not specified |
| Forecast / Est synopsis posting date | Jun 01, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Oct 14, 2026 12:00:00 AM EDT |
| Forecast / Est application response date desc | Not specified |
| Forecast / Est award date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Est project start date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2026 |
| Forecast / Mod comments | Adding "DoW" to the opportunity title |
| Forecast / Create time stamp | May 06, 2026 01:53:35 PM EDT |
| Forecast / Action type | U |
| Forecast / Action date | May 21, 2026 12:20:37 PM EDT |
| Forecast / Created date | May 05, 2026 03:12:11 PM EDT |
| Forecast / Last updated date | May 06, 2026 01:53:35 PM EDT |
| Forecast / Agency details / Code | AMRAA |
| Forecast / Agency details / Seed | DOD-AMRAA |
| Forecast / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Forecast / Agency details / Agency code | DOD-AMRAA |
| Forecast / Agency details / Top agency code | DOD |
| Forecast / Estimated funding formatted | 2,040,000 |
| Forecast / Applicant types 1 / Id | 99 |
| Forecast / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Forecast / Funding instruments 1 / Id | CA |
| Forecast / Funding instruments 1 / Description | Cooperative Agreement |
| Forecast / Funding instruments 2 / Id | G |
| Forecast / Funding instruments 2 / Description | Grant |
| Forecast / Funding activity categories 1 / Id | ST |
| Forecast / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Forecast / Posting date str | 2026-05-05-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-06-01-00-00-00 |
| Forecast / Est application response date str | 2026-10-14-00-00-00 |
| Forecast / Est award date str | 2027-09-30-00-00-00 |
| Forecast / Est project start date str | 2027-09-30-00-00-00 |
| Forecast / Create time stamp str | 2026-05-06-13-53-35 |
| Cfdas 1 / Id | 433151 |
| Cfdas 1 / Opportunity id | 362246 |
| Cfdas 1 / Revision | 1 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Synopsis modified fields | Not specified |
| Forecast modified fields | revision; version; opportunityTitle; forecastDesc; modComments; createTimeStamp |
Forecast changes
revision
version
sendEmail
archiveDate
modComments
createTimeStamp
| Id | 362246 |
| Revision | 3 |
| Opportunity number | HT942526MRPSRA |
| Opportunity title | DoW Melanoma Research Program Survivorship Research Award |
| Owning agency code | DOD-AMRAA |
| Modified comments | Adding "DoW" to the opportunity title |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Synopsis / Opportunity id | 362246 |
| Synopsis / Version | 1 |
| Synopsis / Agency code | DOD-AMRAA |
| Synopsis / Agency name | Jamie Shortall Grant Officer |
| Synopsis / Agency phone | 301-619-2393 |
| Synopsis / Agency address desc | eBRAP Help Desk |
| Synopsis / Agency details / Code | AMRAA |
| Synopsis / Agency details / Seed | DOD-AMRAA |
| Synopsis / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Synopsis / Agency details / Agency code | DOD-AMRAA |
| Synopsis / Agency details / Top agency code | DOD |
| Synopsis / Top agency details / Code | DOD |
| Synopsis / Top agency details / Seed | DOD |
| Synopsis / Top agency details / Agency name | Department of Defense |
| Synopsis / Top agency details / Agency code | DOD |
| Synopsis / Top agency details / Top agency code | DOD |
| Synopsis / Agency contact phone | 301-619-2393 |
| Synopsis / Agency contact name | Jamie Shortall Grant Officer |
| Synopsis / Agency contact desc | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Synopsis / Agency contact email | help@eBRAP.org |
| Synopsis / Agency contact email desc | eBRAP Help Desk |
| Synopsis / Synopsis desc | Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
Distinctive Features: · The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research. · Clinical trials are allowed. |
| Synopsis / Response date | Oct 14, 2026 12:00:00 AM EDT |
| Synopsis / Response date desc | Not specified |
| Synopsis / Posting date | May 21, 2026 12:00:00 AM EDT |
| Synopsis / Archive date | Nov 13, 2026 12:00:00 AM EST |
| Synopsis / Cost sharing | No |
| Synopsis / Number of awards | 2 |
| Synopsis / Estimated funding | 2040000 |
| Synopsis / Estimated funding formatted | 2,040,000 |
| Synopsis / Award ceiling | none |
| Synopsis / Award floor | none |
| Synopsis / Applicant eligibility desc | Not specified |
| Synopsis / Create time stamp | May 21, 2026 12:21:05 PM EDT |
| Synopsis / Created date | May 21, 2026 12:20:37 PM EDT |
| Synopsis / Last updated date | May 21, 2026 12:20:37 PM EDT |
| Synopsis / Applicant types 1 / Id | 99 |
| Synopsis / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Synopsis / Funding instruments 1 / Id | G |
| Synopsis / Funding instruments 1 / Description | Grant |
| Synopsis / Funding activity categories 1 / Id | ST |
| Synopsis / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Synopsis / Response date str | 2026-10-14-00-00-00 |
| Synopsis / Posting date str | 2026-05-21-00-00-00 |
| Synopsis / Archive date str | 2026-11-13-00-00-00 |
| Synopsis / Create time stamp str | 2026-05-21-12-21-05 |
| Agency details / Code | AMRAA |
| Agency details / Seed | DOD-AMRAA |
| Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Agency details / Agency code | DOD-AMRAA |
| Agency details / Top agency code | DOD |
| Top agency details / Code | DOD |
| Top agency details / Seed | DOD |
| Top agency details / Agency name | Department of Defense |
| Top agency details / Agency code | DOD |
| Top agency details / Top agency code | DOD |
| Forecast / Opportunity id | 362246 |
| Forecast / Version | 3 |
| Forecast / Posting date | May 05, 2026 12:00:00 AM EDT |
| Forecast / Archive date | May 20, 2026 12:00:00 AM EDT |
| Forecast / Forecast desc | Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
Distinctive Features: Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $2.04M to fund approximately two Survivorship Research Award applications with total cost caps of $1.02M per award. The maximum period of performance is 3 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027. https://cdmrp.health.mil/pubs/press/2026/mrppreann |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 2 |
| Forecast / Estimated funding | 2040000 |
| Forecast / Award ceiling | none |
| Forecast / Award floor | none |
| Forecast / Agency contact name | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Forecast / Agency contact phone | 301-682-5507 |
| Forecast / Agency contact email | help@eBRAP.org |
| Forecast / Agency contact email desc | eBRAP Help Desk |
| Forecast / Agency code | DOD-AMRAA |
| Forecast / Applicant eligibility desc | Not specified |
| Forecast / Est synopsis posting date | Jun 01, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Oct 14, 2026 12:00:00 AM EDT |
| Forecast / Est application response date desc | Not specified |
| Forecast / Est award date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Est project start date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2026 |
| Forecast / Mod comments | Updated Archive Date |
| Forecast / Create time stamp | May 21, 2026 12:21:05 PM EDT |
| Forecast / Created date | May 05, 2026 03:12:11 PM EDT |
| Forecast / Last updated date | May 21, 2026 12:21:05 PM EDT |
| Forecast / Agency details / Code | AMRAA |
| Forecast / Agency details / Seed | DOD-AMRAA |
| Forecast / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Forecast / Agency details / Agency code | DOD-AMRAA |
| Forecast / Agency details / Top agency code | DOD |
| Forecast / Estimated funding formatted | 2,040,000 |
| Forecast / Applicant types 1 / Id | 99 |
| Forecast / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Forecast / Funding instruments 1 / Id | CA |
| Forecast / Funding instruments 1 / Description | Cooperative Agreement |
| Forecast / Funding instruments 2 / Id | G |
| Forecast / Funding instruments 2 / Description | Grant |
| Forecast / Funding activity categories 1 / Id | ST |
| Forecast / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Forecast / Posting date str | 2026-05-05-00-00-00 |
| Forecast / Archive date str | 2026-05-20-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-06-01-00-00-00 |
| Forecast / Est application response date str | 2026-10-14-00-00-00 |
| Forecast / Est award date str | 2027-09-30-00-00-00 |
| Forecast / Est project start date str | 2027-09-30-00-00-00 |
| Forecast / Create time stamp str | 2026-05-21-12-21-05 |
| Synopsis attachment folders 1 / Id | 79839 |
| Synopsis attachment folders 1 / Opportunity id | 362246 |
| Synopsis attachment folders 1 / Folder type | Full Announcement |
| Synopsis attachment folders 1 / Folder name | FY26 MRP SRA |
| Synopsis attachment folders 1 / Zip lob size | 597271 |
| Synopsis attachment folders 1 / Created date | May 21, 2026 12:20:50 PM EDT |
| Synopsis attachment folders 1 / Last updated date | May 21, 2026 12:21:05 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Id | 352337 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id | 362246 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type | application/pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File name | HT942526MRPSRA_GG.pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File description | FY26 MRP SRA Program Announcement |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size | 759102 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Created date | May 21, 2026 12:21:05 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id | 79839 |
| Synopsis document urls | Not specified |
| Syn att change comments | Not specified |
| Cfdas 1 / Id | 433151 |
| Cfdas 1 / Opportunity id | 362246 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Opportunity pkgs 1 / Id | 292880 |
| Opportunity pkgs 1 / Topportunity id | 362246 |
| Opportunity pkgs 1 / Family id | 14 |
| Opportunity pkgs 1 / Dialect | XFDL2.2 |
| Opportunity pkgs 1 / Opportunity number | HT942526MRPSRA |
| Opportunity pkgs 1 / Opportunity title | DoW Melanoma Research Program Survivorship Research Award |
| Opportunity pkgs 1 / Cfda number | 12.420 |
| Opportunity pkgs 1 / Opening date | 2026-05-21 |
| Opportunity pkgs 1 / Closing date | 2026-10-14 |
| Opportunity pkgs 1 / Owning agency code | DOD-AMRAA |
| Opportunity pkgs 1 / Agency details / Code | AMRAA |
| Opportunity pkgs 1 / Agency details / Seed | DOD-AMRAA |
| Opportunity pkgs 1 / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Opportunity pkgs 1 / Agency details / Agency code | DOD-AMRAA |
| Opportunity pkgs 1 / Agency details / Top agency code | DOD |
| Opportunity pkgs 1 / Top agency details / Code | DOD |
| Opportunity pkgs 1 / Top agency details / Seed | DOD |
| Opportunity pkgs 1 / Top agency details / Agency name | Department of Defense |
| Opportunity pkgs 1 / Top agency details / Agency code | DOD |
| Opportunity pkgs 1 / Top agency details / Top agency code | DOD |
| Opportunity pkgs 1 / Program title | Military Medical Research and Development |
| Opportunity pkgs 1 / Contact info | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Opportunity pkgs 1 / Grace period | 0 |
| Opportunity pkgs 1 / Electronic required | Y |
| Opportunity pkgs 1 / Expected application count | 20 |
| Opportunity pkgs 1 / Expected application size | 1000000 |
| Opportunity pkgs 1 / Open to applicant type | 1 |
| Opportunity pkgs 1 / Is multi project | N |
| Opportunity pkgs 1 / Extension | |
| Opportunity pkgs 1 / Mimetype | application/pdf |
| Opportunity pkgs 1 / Last update | May 21, 2026 12:22:18 PM EDT |
| Opportunity pkgs 1 / Workspace compatible flag | Y |
| Opportunity pkgs 1 / Package id | PKG00292880 |
| Opportunity pkgs 1 / Opening date str | 2026-05-21-00-00-00 |
| Opportunity pkgs 1 / Closing date str | 2026-10-14-00-00-00 |
| Closed opportunity pkgs | Not specified |
| Original due date | Oct 14, 2026 12:00:00 AM EDT |
| Original due date desc | Not specified |
| Synopsis modified fields | Not specified |
| Forecast modified fields | revision; version; sendEmail; archiveDate; modComments; createTimeStamp |
| Error messages | Not specified |
| Syn post date in past | Yes |
| Doc type | synopsis |
| Forecast hist count | 2 |
| Synopsis hist count | 0 |
| Assist compatible | No |
| Assist url | Not specified |
| Related opps | Not specified |
| Ost | POSTED |
Related Documents
HT942526MRPSRA_GG.pdf
Packages
| Agency Contact Information: | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00292880 | 2026-05-21 | 2026-10-14 | View |
Package 1
Instructions
PKG00292916-instructions.pdf
Mandatory forms
RR_SF424_5_0-V5.0.pdf
AttachmentForm_1_2-V1.2.pdf
RR_KeyPersonExpanded_4_0-V4.0.pdf
RR_Budget_3_0-V3.0.pdf
PerformanceSite_4_0-V4.0.pdf
Optional forms
RR_SubawardBudget30_3_0-V3.0.pdf
